Philip Toleikis
Chief Tech/Sci/R&D Officer presso SERNOVA CORP.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Philip M.
Toleikis is currently the Director & Chief Technology Officer at Sernova Corp.
since 2023.
He is also a Member of the Medway Working Group.
Previously, he worked as the VP-Pharmacology, Research & Development at Angiotech Pharmaceuticals, Inc. from 1999 to 2006.
Dr. Toleikis holds a doctorate degree from the University of British Columbia, a graduate degree from the University of Michigan, and an undergraduate degree from the University of Vermont.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SERNOVA CORP.
1.74% | 25/04/2023 | 5 273 598 ( 1.74% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Philip Toleikis
| Società | Posizione | Inizio |
|---|---|---|
| SERNOVA CORP. | Chief Tech/Sci/R&D Officer | 05/09/2023 |
| Medway Working Group | Corporate Officer/Principal | - |
Precedenti posizioni note di Philip Toleikis
| Società | Posizione | Fine |
|---|---|---|
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 01/01/2006 |
Formazione di Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
- Borsa valori
- Insiders
- Philip Toleikis
